We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OMC:NYSEOmnicom Group Inc. Analysis

Data as of 2026-03-10 - not real-time

$81.31

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Omnicom delivered a 27.9% year‑over‑year revenue increase to $5.53 billion, crushing consensus estimates by more than 20%. The top‑line strength lifted the stock sharply, with the price jumping 12‑15% on the day of the release. Despite the revenue beat, non‑GAAP earnings of $2.59 per share fell 11.8% short of forecasts, leaving a trailing profit margin of ‑0.3%. The share price of $81.31 now sits above its 20‑day, 50‑day and 200‑day moving averages (79.38, 78.15 and 75.87), confirming a bullish technical backdrop. The MACD line remains bullish (2.40 above the signal at 2.16) and the RSI of 52 signals neutral momentum without overbought pressure. Volume has been decreasing, which could temper the recent rally, but the 30‑day volatility of 64% reflects a market that is still pricing in uncertainty.
Valuation metrics show a forward P/E of 6.45, far below the industry average of 18.2, suggesting the stock is undervalued relative to peers. A dividend yield of 3.81% backed by a payout ratio of 41% and strong free‑cash‑flow generation ($4.5 billion) points to a sustainable dividend stream. The balance sheet carries $11.3 billion of debt against $6.9 billion of cash, resulting in a debt‑to‑equity of 86%, which is manageable but warrants monitoring. Analyst consensus remains Buy with a median price target of $101.5, implying roughly 24% upside from current levels. Sector exposure spans North America, EMEA and APAC, providing diversification but also introducing medium‑level geographic and regulatory risk. Overall, the combination of robust revenue growth, attractive valuation and a solid dividend makes Omnicom a compelling buy for investors comfortable with moderate volatility.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Revenue beat and strong price momentum
  • Bullish technical indicators
  • Attractive dividend yield

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Profit margin miss may linger
  • Debt level requires watch
  • Valuation still attractive but volatility high

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustained revenue growth trajectory
  • Undervalued relative to peers
  • Stable dividend and cash flow generation

Key Metrics & Analysis

Financial Health

Revenue Growth27.90%
Profit Margin-0.32%
P/E Ratio6.4
ROE0.48%
ROA3.77%
Debt/Equity86.31
P/B Ratio2.1
Op. Cash Flow$2.9B
Free Cash Flow$4.5B
Industry P/E18.2

Technical Analysis

TrendBullish
RSI52.9
Support$66.66
Resistance$87.17
MA 20$79.38
MA 50$78.15
MA 200$75.87
MACDBullish
VolumeDecreasing
Fear & Greed Index78.45

Valuation

Fair Value$530.27
Target Price$100.90
Upside/Downside24.09%
GradeUndervalued
TypeBlend
Dividend Yield3.81%

Risk Assessment

Beta0.74
Volatility64.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.